<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">606240780</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20210128101309.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">210128e20150101xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1007/s00508-014-0626-1</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)springer-10.1007/s00508-014-0626-1</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Self-reported frequency and impact of hypoglycaemic events in insulin-treated diabetic patients in Austria</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Raimund Weitgasser, Sandra Lopes]</subfield>
  </datafield>
  <datafield tag="246" ind1="1" ind2=" ">
   <subfield code="a">Häufigkeit und Auswirkung von Hypoglykämien bei insulinbehandelten Diabetes-Patienten in Österreich</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">Background: Hypoglycaemia is a common side effect of insulin therapy and presents a barrier to diabetes management, however, limited data exist on the real-world frequency of events. We investigated the self-reported rates of non-severe and severe hypoglycaemic events in Austria. We also explored hypoglycaemia awareness, patient-physician communication and the health-related and economic impact of events. Methods: People with Type-1 or insulin-treated Type-2 diabetes &gt;15 years of age completed up to 4 questionnaires (weekly intervals). Non-severe hypoglycaemic events were defined by requiring no assistance while severe hypoglycaemic events need help from a third party. Results: Overall, 553 respondents (40% Type-1, 60% Type-2) enrolled, providing a total of 1,773 patient-weeks. The mean annual non-severe event frequencies were 85 for Type-1 and 15-28 for Type-2 (depending on insulin regimen). In respondents who experienced ≥1 non-severe event in the study period, annual rates were 18% higher in Type-1 and 77% higher in Type-2. The proportion of respondents reporting ‘awareness' of hypoglycaemic symptoms was 48% for Type-1 and 43-61% for Type-2 respondents. The proportion of respondents who rarely/never inform their physician of hypoglycaemic events was 67% (Type-1) and 43-53% (Type-2). The most commonly reported health-related impacts were tiredness/fatigue (58% of events) and reduced alertness (41% of events). Conclusion: Non-severe hypoglycaemic events are common in Type-1 and insulin-treated Type-2 diabetes patients in Austria. There may be subgroups of patients who are predisposed to higher rates of non-severe events. Even non-severe events have a negative impact on physical and emotional well-being.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">The Author(s), 2014</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Diabetes mellitus</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Hypoglycaemia</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Insulin</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Quality of life</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Hypoglykämie</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="690" ind1=" " ind2="7">
   <subfield code="a">Lebensqualität</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Weitgasser</subfield>
   <subfield code="D">Raimund</subfield>
   <subfield code="u">Department of Internal Medicine, Diakonissen Hospital Salzburg, Salzburg, Austria</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Lopes</subfield>
   <subfield code="D">Sandra</subfield>
   <subfield code="u">Novo Nordisk Scandinavia AB, Region Danmark, Arne Jacobsens Allé 17, 9. sal, 2300, Copenhagen, Denmark</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Wiener klinische Wochenschrift</subfield>
   <subfield code="d">Springer Vienna</subfield>
   <subfield code="g">127/1-2(2015-01-01), 36-44</subfield>
   <subfield code="x">0043-5325</subfield>
   <subfield code="q">127:1-2&lt;36</subfield>
   <subfield code="1">2015</subfield>
   <subfield code="2">127</subfield>
   <subfield code="o">508</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1007/s00508-014-0626-1</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">Springer special CC-BY-NC licence</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-springer</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1007/s00508-014-0626-1</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Weitgasser</subfield>
   <subfield code="D">Raimund</subfield>
   <subfield code="u">Department of Internal Medicine, Diakonissen Hospital Salzburg, Salzburg, Austria</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Lopes</subfield>
   <subfield code="D">Sandra</subfield>
   <subfield code="u">Novo Nordisk Scandinavia AB, Region Danmark, Arne Jacobsens Allé 17, 9. sal, 2300, Copenhagen, Denmark</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Wiener klinische Wochenschrift</subfield>
   <subfield code="d">Springer Vienna</subfield>
   <subfield code="g">127/1-2(2015-01-01), 36-44</subfield>
   <subfield code="x">0043-5325</subfield>
   <subfield code="q">127:1-2&lt;36</subfield>
   <subfield code="1">2015</subfield>
   <subfield code="2">127</subfield>
   <subfield code="o">508</subfield>
  </datafield>
 </record>
</collection>
